Intra Cellular Therapies | ITCI - Market Capitalization


Intra Cellular Therapies reported $12.77B in Market Capitalization this April of 2025, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Prothena USD 514M 11M Dec/2025
RedHill Biopharma USD 12M 17M Jun/2024
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024